☰

Cassie K. Chou, Ph.D. - Publications

Affiliations: 
2012 Immunology University of Washington, Seattle, Seattle, WA 
Area:
Immunology, Cell Biology, Oncology
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hirayama AV, Chou CK, Miyazaki T, Steinmetz RN, Di HA, Fraessle SP, Gauthier J, Fiorenza S, Hawkins RM, Overwijk WW, Riddell SR, Marcondes AMQ, Turtle CJ. A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR-T cell immunotherapy. Blood Advances. PMID 36332004 DOI: 10.1182/bloodadvances.2022008697  0.328
2021 Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, Hsu JL, Chou CW, Sun X, Deng Y, Chou CK, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nature Communications. 12: 832. PMID 33547304 DOI: 10.1038/s41467-021-21099-2  0.334
2020 Gauthier J, Bezerra ED, Hirayama AV, Fiorenza S, Sheih A, Chou CK, Kimble EL, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Jamieson AW, Bar M, Cassaday R, et al. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B cell malignancies. Blood. PMID 32967009 DOI: 10.1182/blood.2020006770  0.326
2019 Chou CK, Turtle CJ. Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy. Bone Marrow Transplantation. 54: 780-784. PMID 31431714 DOI: 10.1038/S41409-019-0602-5  0.385
2019 Chou C, Fraessle S, Steinmetz R, Hawkins RM, Phi T, Busch D, Miyazaki T, Marcondes MQ, Riddell SR, Turtle CJ. Combination of NKTR-255, a Polymer Conjugated Human IL-15, with CD19 CAR T Cell Immunotherapy in a Preclinical Lymphoma Model Blood. 134: 2866-2866. DOI: 10.1182/Blood-2019-125960  0.309
2012 Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD. Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. Journal of Immunology (Baltimore, Md. : 1950). 189: 3936-46. PMID 22984076 DOI: 10.4049/Jimmunol.1201415  0.388
Show low-probability matches.